The Importance of Measuring Advanced Glycation Endproducts in Diabetes
Author Information
Author(s): Meerwaldt Robbert, Links Thera, Zeebregts Clark, Tio Rene, Hillebrands Jan-Luuk, Smit Andries
Primary Institution: University Medical Center Groningen
Hypothesis
Does advanced glycation endproducts (AGEs) accumulation predict cardiovascular complications in diabetic patients?
Conclusion
AGE accumulation is a strong predictor of cardiovascular complications and mortality in diabetic patients.
Supporting Evidence
- Diabetic patients have a higher risk of cardiovascular disease due to AGEs.
- AGE levels correlate with the severity of coronary heart disease.
- AGE accumulation predicts long-term complications in diabetes.
- Interventions that lower AGE levels may reduce cardiovascular risks.
Takeaway
In diabetes, measuring certain harmful substances called AGEs can help doctors understand how likely a patient is to have heart problems.
Methodology
This review article summarizes existing studies on the role of AGEs in diabetes and their association with cardiovascular disease.
Limitations
The review is based on existing literature, which may have varying methodologies and sample sizes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website